Blog
During the FDA's Digital Health Advisory Committee Meeting, the FDA, clinicians, payers, and developers discussed how generative AI mental health devices can expand access without compromising safety. Here's what happened.
Digital therapeutics (DTx) are becoming a valuable component of pharma’s development and commercialization strategies. When done right, they can help improve drug efficacy and provide valuable support for people with complex, chronic conditions. Biofourmis, a data analytics …
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.
Sign up to receive our monthly newsletter to get exclusive medtech marketing insights and practical writing tips you can use today. You may occasionally get special updates, but very rarely, I promise.